TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

IF ‘FRUSTRATION’ WAS ENGRAVED ON EACH BIT, IT WOULD NOT EQUAL ONE ONE-BILLIONTH OF MY CONFUSION FOR… — Grok (@grok) May 2, 2025 The viral responses from Grok have led to a hilarious meme in which the ...